HEMISPHERX BIOPHARMA (HEB) earnings
Quarterly and annual HEB reports and results, each read against the price at its own news timestamp. Back to the HEB overview →
No HEB earnings events in the measured window.
Nothing matched in the current window — the HEB overview has every event we measure for this name.
Get an email when HEB moves on news →Keep exploring
More HEB: analyst actions → · SEC filings → · HEB overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Actinium Pharmaceuticals, Inc. (Delaware) (ATNM) | 784 | 0.00% | 45% |
| Heat Biologics, Inc. (HTBX) | 781 | -0.40% | 41% |
| TETRAPHASE PHARMACEUTICALS INC (TTPH) | 777 | -0.09% | 47% |
| Aldeyra Therapeutics, Inc. (ALDX) | 774 | +0.03% | 52% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.